– Most commonly reported (>20%) treatment related-adverse events: nausea (54%), diarrhea (48%), vomiting (34%), asthenia (28%) and increased in alanine aminotransferase level (23%). – Grade 3/4 hyponatremia according to CTCAE† was reported in 3% of patients. Here, GPT is linked to Hyponatremia.